A recent trial revealed that a single injection of a monoclonal antibody, benralizumab, could be more effective than standard steroid tablets during asthma or COPD flare-ups.
Medical Daily will always protect your security and privacy. Please read our detailed Privacy Policy
Please do not reply to this email. Click here to adjust your notification preferences or unsubscribe.
